Deva Holding AS | DEVA - Cost Of Sales

Stock Price
60.90
Daily Change
0.45 0.74%
Monthly
-5.73%
Yearly
2.18%
Q2 Forecast
58.24

Deva Holding AS reported TRY991.13M in Cost of Sales for its fiscal quarter ending in September of 2023.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 350.4M 26.05M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025